Clostridioides Difficile Infection
📧 Sign up to get email alerts when something new happens for Clostridioides Difficile Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile Infection [Phase 3]
Phase 3, multi-center, single-arm trial evaluating RBX2660 delivered by colonoscopy in adults with recurrent Clostridioides difficile infect…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients [Phase 2]
Phase 2 trial evaluating vancomycin for NAAT+/EIA- Clostridioides difficile infection in patients with hematologic diseases, including bone …
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: High- Fiber/ Low-fat Diet for Prevention of Recurrent Clostridioides Difficile Infection in Oncology [NA]
A completed clinical trial examined whether a high-fiber, low-fat diet can prevent recurrent Clostridioides difficile infection in oncology …
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Effect of Oral Microbiota on MDRO Decolonization [Phase 1, Phase 2]
This clinical trial explored whether altering the oral microbiota can promote decolonization of multidrug-resistant organisms in participant…
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: Fecal Microbiota Transplant [Phase 4]
A Phase 4 clinical trial evaluating fecal microbiota transplant for Clostridioides difficile infection has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: SYN-004 Safety and Tolerability in Allo-HCT Subjects [Phase 1, Phase 2]
Phase 1/Phase 2 trial evaluating safety and tolerability of SYN-004 in adults undergoing allogeneic hematopoietic stem cell transplantation,…
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: FMT Capsules for rCDI [Phase 3]
Phase 3 trial evaluating fecal microbiota transplant capsules for recurrent Clostridioides difficile infection, currently not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: Bezlotoxumab Yielded Outcomes by Addressing Personalized Needs in Clostridioides Difficile Infection [Phase 2]
A Phase 2 trial of bezlotoxumab for Clostridioides difficile infection examined outcomes tailored to personalized patient needs, with result…
-
CLINICAL_TRIALS trial_result · 2026-01-30Clinical Trial Update: Safety and Tolerability of AZD5148 in Japanese Participants [Phase 1]
Phase 1 safety and tolerability study of AZD5148 in Japanese participants has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: REBYOTA™ Prospective Registry
A prospective registry update for REBYOTA evaluating its use to prevent recurrence of Clostridioides difficile infection has been completed.
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Host Immune Response to Clostridium Difficile Infection (ICD) [NA]
A completed clinical trial update from Hospices Civils de Lyon investigates the host immune response to Clostridioides difficile infection.
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: C.Difficile Observational Study
AstraZeneca-sponsored observational study on Clostridioides difficile infection has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: Initial Vancomycin Taper for the Prevention of Recurrent Clostridium Difficile Infection [Phase 3]
A Phase 3 trial evaluating an initial vancomycin taper to prevent recurrent Clostridioides difficile infection has completed.
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: The Clostridioides Difficile Trial of REC-3964 [Phase 2]
A Phase 2 trial of REC-3964 for recurrent Clostridioides difficile infection has been terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: Optimal Treatment for Recurrent Clostridium Difficile [Phase 4]
Phase 4 trial evaluating optimal treatment for recurrent Clostridioides difficile infection has terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2025-10-09Clinical Trial Update: Prevention of Recurrence of Clostridioides Difficile Colitis With Ursodeoxycholic Acid (UCDA) as a Supplement to Standard Therapy [EARLY_Phase 1]
An early-phase 1 trial is examining ursodeoxycholic acid as a supplement to standard therapy to prevent recurrence of Clostridioides diffici…
-
CLINICAL_TRIALS trial_result · 2025-09-23Clinical Trial Update: Efficacy and Safety of Teicoplanin in CDAD [Phase 4]
Phase 4 trial evaluating teicoplanin for Clostridioides difficile infection–associated diarrhea and colitis was terminated; no efficacy or s…
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Animal-Assisted Visitation Program Chlorhexidine Trial [Phase 4]
Phase 4 clinical trial update on an animal-assisted visitation program using chlorhexidine, sponsored by Johns Hopkins Bloomberg School of P…
-
CLINICAL_TRIALS trial_result · 2025-07-11Clinical Trial Update: Effect of Expanding (Gloving) Barrier Precautions for Reducing Clostridium Difficile Acquisition (and Infection) in VA [NA]
A completed VA clinical trial evaluated whether expanding barrier precautions (gloving) reduces acquisition and infection with Clostridioide…
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Prevention of Recurrent Clostridium Difficile Infection (CDI) in Patients With Inflammatory Bowel Disease (IBD). [Phase 4]
Phase 4 trial evaluating prevention of recurrent Clostridioides difficile infection in patients with inflammatory bowel disease. The study w…
-
CLINICAL_TRIALS trial_result · 2025-05-25Clinical Trial Update: Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection [Phase 2]
This Phase 2 trial evaluated the efficacy of oral vancomycin prophylaxis to prevent recurrent Clostridioides difficile infection. The study …
-
CLINICAL_TRIALS trial_result · 2025-05-25Clinical Trial Update: Evaluation of CRS3123 vs. Oral Vancomycin in Adult Patients With Clostridioides Difficile Infection [Phase 2]
A Phase 2 trial comparing CRS3123 to oral vancomycin for adult Clostridioides difficile infection has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2025-04-08Clinical Trial Update: Safety of Stool Transplant for Patients With Difficult to Treat C. Difficile Infection [NA]
This clinical trial result summarizes the safety of fecal microbiota transplantation in patients with difficult-to-treat Clostridioides diff…
-
CLINICAL_TRIALS trial_result · 2025-03-25Clinical Trial Update: Primary or Recurrent Clostridioides Difficile Infection Treatment With Capsules of Lyophilised Faecal Microbiota vs Fidaxomicin [Phase 3]
Phase 3 trial comparing capsules of lyophilised faecal microbiota to fidaxomicin for primary or recurrent Clostridioides difficile infection…
-
CLINICAL_TRIALS trial_result · 2025-03-18Clinical Trial Update: Exploratory Study to Assess Delivery of LMN-201 Components Via Enteric Capsules in the Gut of Individuals With Ostomies [Phase 1]
A Phase 1 exploratory trial evaluating delivery of LMN-201 components via enteric capsules in ostomy patients with Clostridioides difficile …